Pfizer beats expectations in Q2 operating results, raising yearly guidance

NEW YORK, July 30 (Xinhua) -- U.S. drugmaker Pfizer Inc. on Tuesday reported better-than-expected operating results in the second quarter and raised its operating guidance for 2024.

Pfizer recorded 13.28 billion U.S. dollars of revenues in Q2, up 2 percent year on year and higher than market expectation of 12.96 billion U.S. dollars.